Research Article

Comparison of Amiodarone and Propafenone in Blanking Period after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation: A Propensity Score-Matched Study

Table 1

Baseline characteristics of population.

VariableOriginal amiodarone group ()Original propafenone group ()Amiodarone group ()Propafenone group ()

General information
Age, years+63 (54-67)59 (52-65)0.01863 (54−67)62 (56−69)0.398
Sex, M/F+132/55169/1360.00192/4384/510.307
BMI, kg/m224.4 (22.5 − 26.8)24.3 (22.0 − 26.4)0.25824.4 (22.5 − 26.1)24.3 (22.4 − 26.4)0.943
AF type
PAF/PeAF+138/49290/15<0.001118/17120/150.706
Medical history
FL21 (11.2)37 (12.1)0.76317 (12.6)11 (8.1)0.231
AT+19 (10.2)58 (19.0)0.00915 (11.1)16 (11.9)0.849
HT92 (49.2)133 (43.6)0.22767 (49.6)74 (54.8)0.394
HHD+53 (28.3)55 (18.1)0.00336 (26.7)40 (29.6)0.588
CAD+29 (15.5)23 (7.5)0.00518 (13.3)20 (14.8)0.726
DM+8 (4.3)4 (1.5)0.0383 (2.2)4 (2.9)0.702
VHD+27 (14.4)30 (9.9)0.12219 (14.1)18 (13.1)0.860
GUCH9 (4.8)11 (3.7)0.5115 (3.7)4 (3.0)0.735
Diabetes+37 (19.8)41 (13.4)0.06119 (14.1)25 (18.5)0.323
Stoke/TIA+35 (18.7)38 (12.5)0.05822 (16.3)27 (20.0)0.430
PVD+8 (4.3)4 (1.3)0.0383 (2.2)3 (2.2)1.000
HLP+57 (30.5)122 (40.0)0.03339 (28.9)45 (33.3)0.430
HUA+48 (25.7)59 (19.4)0.09930 (22.2)29 (21.5)0.863
Laboratory test results
TC+, mmol/L0.1350.969
LDL-C+, mmol/L0.0270.695
NT-proBNP+, ng/L187.0 (61.0−567.0)92.0 (46.0−212.0)<0.001123.0 (53.0−440.0)132.0 (60.0−409.0)0.767
CR+, umol/L0.0110.434
Echocardiogram parameters
LAD, mm0.9900.136
LVEF, %0.7400.248
CHA2DS2VASc0.0690.239
Medication use after RFCA
β-Blockers+32 (17.0)39 (12.9)0.18521 (15.6)22 (16.3)0.868
ACEI/ARB56 (29.9)91 (29.9)1.00040 (29.6)55 (40.7)0.056
Statins+55 (29.4)110 (36.1)0.12940 (29.6)46 (34.1)0.433

+PSM variables. Values are , medians (interquartile range), / or (%). BMI = body mass index; PAF = paroxysmal atrial fibrillation; PeAF = persistent atrial fibrillation; HT = hypertension; GUCH = grown up with congenital heart disease; LAD = left atrial diameter; LVEF = left ventricular ejection fraction.